Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Imiquimod 5% cream reduced equine sarcoids in most cases.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Cetuximab can cause excessive eyelash growth.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The cat's skin condition improved significantly with medication, with no relapse.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Depression worsens eczema severity, increases inflammation, and lowers quality of life.

Ruxolitinib cream may help treat severe hair loss in children.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

EPDS and MS might share an immune-related cause.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.